Leukemic ALCL cells were obtained from a peripheral blood sample of a refractory ALK+ ALCL patient (Supplementary Table S1). For the initial tumorgraft implants, lymphoma cells (10–12.5 × 10 6, 200 μl ...

Anaplastic sarcoma of the kidney presents as a large renal mass, and its major gross and histologic features include the presence of cysts, marked anaplasia in the spindle cell component, and areas of ...

An ependymoma is a rare tumor that begins in the central nervous system, which comprises the brain and spinal cord. Ependymoma cancer is anaplastic if the cancer cells grow rapidly and are unusual in ...

Phase IIa Study of PLX2853 in Gynecologic Cancers With Known ARID1A Mutation and Phase Ib/IIa Study of PLX2853/Carboplatin in Platinum-Resistant Epithelial Ovarian Cancer Adult-onset neuroblastoma ...

Primary non-Hodgkin's lymphoma of the CNS treated with BVAM or CHOD/BVAM chemotherapy before radiotherapy. During the last few years, the application of CD30 monoclonal antibodies has led to the ...

The study covered in this summary was published on Research Square as a preprint and has not yet been peer reviewed. Anaplastic thyroid cancer is a rare thyroid malignancy; disease-specific mortality ...

LONDON--(BUSINESS WIRE)--The global anaplastic thyroid cancer drugs market is expected to post a CAGR of more than 4% during the period 2019-2023, according to the latest market research report by ...

Anaplastic thyroid cancer (ATC), a rare yet highly aggressive malignancy, continues to represent a major clinical challenge. A recent review published in Genes & Diseases offers a comprehensive ...

Medullary Thyroid Cancer - For the most part, when people think of thyroid cancer, they think of an easily treatable disease. The reality of the matter is that this is seldomly the case. Thyroid ...

LONDON--(BUSINESS WIRE)--Technavio has announced their latest pipeline analysis report on the anaplastic thyroid cancer market. The report includes a detailed analysis of the pipeline molecules under ...

Oncogenic fusion genes consisting of EML4 and anaplastic lymphoma kinase (ALK) are present in a subgroup of non–small-cell lung cancers, representing 2 to 7% of such tumors. We explored the ...